BSH attended the 21st Annual Sickle Cell & Thalassaemia Conference (ASCAT 2026) in London last week, which brought together clinicians, researchers, patients, advocates and policymakers from the UK and internationally. This year’s theme, “Building Care That Lasts: Sustainability in Haemoglobinopathy Care”, explored how advances in research and treatment can be translated into equitable, high-quality and sustainable care, with discussions spanning emerging therapies, workforce development, health inequalities, policy and access to treatment.
The conference provided a valuable opportunity to hear about the latest developments in haemoglobinopathy care, see the contribution of BSH members to this important area of practice,...
2 days ago
